JPMorgan Chase & Co’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3
| Closed | -$26 | – | 6584 |
|
|
2024
Q2 | $26 | Hold |
3
| – | – | ﹤0.01% | 6116 |
|
|
2024
Q1 | $26 | Buy |
3
+1
| +50% | +$9 | ﹤0.01% | 6127 |
|
|
2023
Q4 | $15 | Buy |
2
+1
| +100% | +$8 | ﹤0.01% | 6350 |
|
|
2023
Q3 | $6 | Buy |
+1
| New | +$6 | ﹤0.01% | 6388 |
|
|
2022
Q2 | – | Sell |
-463
| Closed | -$10K | – | 5982 |
|
|
2022
Q1 | $10K | Sell |
463
-7,451
| -94% | -$161K | ﹤0.01% | 5397 |
|
|
2021
Q4 | $476K | Buy |
7,914
+2,376
| +43% | +$143K | ﹤0.01% | 4107 |
|
|
2021
Q3 | $520K | Buy |
5,538
+2,723
| +97% | +$256K | ﹤0.01% | 3934 |
|
|
2021
Q2 | $466K | Sell |
2,815
-7,764
| -73% | -$1.29M | ﹤0.01% | 4038 |
|
|
2021
Q1 | $2.04M | Buy |
+10,579
| New | +$2.04M | ﹤0.01% | 3237 |
|